Evripidis Lanitis

3.8k total citations
25 papers, 2.2k citations indexed

About

Evripidis Lanitis is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Evripidis Lanitis has authored 25 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Evripidis Lanitis's work include CAR-T cell therapy research (18 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (8 papers). Evripidis Lanitis is often cited by papers focused on CAR-T cell therapy research (18 papers), Immune Cell Function and Interaction (9 papers) and Immunotherapy and Immune Responses (8 papers). Evripidis Lanitis collaborates with scholars based in Switzerland, United States and Greece. Evripidis Lanitis's co-authors include George Coukos, Melita Irving, Denarda Dangaj Laniti, Daniel J. Powell, Raphael Sandaltzopoulos, Mathilde Poussin, Nathalie Scholler, De-Gang Song, Alex W. Klattenhoff and Carl H. June and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Nature reviews. Immunology.

In The Last Decade

Evripidis Lanitis

24 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evripidis Lanitis Switzerland 19 1.6k 887 695 562 367 25 2.2k
Clare Y. Slaney Australia 23 1.8k 1.2× 1.2k 1.4× 761 1.1× 434 0.8× 304 0.8× 38 2.6k
Elena Sotillo United States 22 1.6k 1.0× 588 0.7× 980 1.4× 491 0.9× 396 1.1× 45 2.3k
Stefanie R. Bailey United States 19 1.6k 1.0× 1.1k 1.2× 699 1.0× 468 0.8× 383 1.0× 35 2.3k
Kheng Newick United States 14 1.9k 1.2× 897 1.0× 819 1.2× 608 1.1× 445 1.2× 15 2.4k
Selene Nuñez-Cruz United States 18 1.1k 0.7× 891 1.0× 584 0.8× 365 0.6× 322 0.9× 35 1.9k
Fabiana Perna United States 20 1.5k 0.9× 643 0.7× 1.3k 1.9× 399 0.7× 455 1.2× 62 2.7k
Liang‐Chuan S. Wang United States 15 1.7k 1.1× 949 1.1× 637 0.9× 406 0.7× 393 1.1× 21 2.2k
Meera Murgai United States 8 1.5k 0.9× 761 0.9× 708 1.0× 511 0.9× 370 1.0× 13 2.0k
Dhanalakshmi Chinnasamy United States 16 1.6k 1.0× 1.0k 1.2× 778 1.1× 371 0.7× 580 1.6× 25 2.2k
Olga Dakhova United States 24 2.4k 1.5× 914 1.0× 1.1k 1.6× 712 1.3× 822 2.2× 40 3.1k

Countries citing papers authored by Evripidis Lanitis

Since Specialization
Citations

This map shows the geographic impact of Evripidis Lanitis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evripidis Lanitis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evripidis Lanitis more than expected).

Fields of papers citing papers by Evripidis Lanitis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evripidis Lanitis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evripidis Lanitis. The network helps show where Evripidis Lanitis may publish in the future.

Co-authorship network of co-authors of Evripidis Lanitis

This figure shows the co-authorship network connecting the top 25 collaborators of Evripidis Lanitis. A scholar is included among the top collaborators of Evripidis Lanitis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evripidis Lanitis. Evripidis Lanitis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lanitis, Evripidis, Melita Irving, & George Coukos. (2025). Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy. Nature reviews. Immunology. 25(11). 831–846. 4 indexed citations
2.
Kosti, Paris, et al.. (2025). Potent and durable control of mesothelin-expressing tumors by a novel T cell-secreted bi-specific engager. Journal for ImmunoTherapy of Cancer. 13(3). e010063–e010063.
3.
Corría-Osorio, Jesús, Santiago J. Carmona, Massimo Andreatta, et al.. (2023). Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells. Nature Immunology. 24(5). 869–883. 27 indexed citations
4.
Irving, Melita, Evripidis Lanitis, Denis Migliorini, Zoltán Ivics, & Sònia Guedan. (2021). Choosing the Right Tool for Genetic Engineering: Clinical Lessons from Chimeric Antigen Receptor-T Cells. Human Gene Therapy. 32(19-20). 1044–1058. 67 indexed citations
5.
Lanitis, Evripidis, Paris Kosti, Catherine Ronet, et al.. (2021). VEGFR-2 redirected CAR-T cells are functionally impaired by soluble VEGF-A competition for receptor binding. Journal for ImmunoTherapy of Cancer. 9(8). e002151–e002151. 38 indexed citations
6.
Lanitis, Evripidis, George Coukos, & Melita Irving. (2020). All systems go: converging synthetic biology and combinatorial treatment for CAR-T cell therapy. Current Opinion in Biotechnology. 65. 75–87. 38 indexed citations
7.
Monnot, Gwennaëlle, Amaia Martínez-Usatorre, Evripidis Lanitis, et al.. (2019). miR-155 Overexpression in OT-1 CD8+ T Cells Improves Anti-Tumor Activity against Low-Affinity Tumor Antigen. Molecular Therapy — Oncolytics. 16. 111–123. 19 indexed citations
8.
Lanitis, Evripidis, Denarda Dangaj Laniti, Melita Irving, & George Coukos. (2017). Mechanisms regulating T-cell infiltration and activity in solid tumors. Annals of Oncology. 28(suppl_12). xii18–xii32. 283 indexed citations
9.
Roberti, Annalisa, Maria Pamela Dobay, Bettina Bisig, et al.. (2016). Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. Nature Communications. 7(1). 12602–12602. 115 indexed citations
10.
Smith, Jenessa B., Evripidis Lanitis, Denarda Dangaj Laniti, et al.. (2016). Tumor Regression and Delayed Onset Toxicity Following B7-H4 CAR T Cell Therapy. Molecular Therapy. 24(11). 1987–1999. 45 indexed citations
11.
Lanitis, Evripidis, Melita Irving, & George Coukos. (2015). Targeting the tumor vasculature to enhance T cell activity. Current Opinion in Immunology. 33. 55–63. 264 indexed citations
12.
Lanitis, Evripidis, Jenessa B. Smith, Denarda Dangaj Laniti, et al.. (2014). A Human ErbB2-Specific T-Cell Receptor Confers Potent Antitumor Effector Functions in Genetically Engineered Primary Cytotoxic Lymphocytes. Human Gene Therapy. 25(8). 730–739. 14 indexed citations
13.
Giannakakis, Antonis, Athanasios Karapetsas, Denarda Dangaj Laniti, et al.. (2014). Overexpression of SMARCE1 is associated with CD8+ T-cell infiltration in early stage ovarian cancer. The International Journal of Biochemistry & Cell Biology. 53. 389–398. 14 indexed citations
14.
Laniti, Denarda Dangaj, Evripidis Lanitis, Aizhi Zhao, et al.. (2013). Novel Recombinant Human B7-H4 Antibodies Overcome Tumoral Immune Escape to Potentiate T-Cell Antitumor Responses. Cancer Research. 73(15). 4820–4829. 98 indexed citations
15.
Lanitis, Evripidis, Mathilde Poussin, Alex W. Klattenhoff, et al.. (2013). Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo. Cancer Immunology Research. 1(1). 43–53. 285 indexed citations
16.
Urbańska, Katarzyna, Evripidis Lanitis, Mathilde Poussin, et al.. (2012). A Universal Strategy for Adoptive Immunotherapy of Cancer through Use of a Novel T-cell Antigen Receptor. Cancer Research. 72(7). 1844–1852. 265 indexed citations
17.
Lanitis, Evripidis, Denarda Dangaj Laniti, Ian S. Hagemann, et al.. (2012). Primary Human Ovarian Epithelial Cancer Cells Broadly Express HER2 at Immunologically-Detectable Levels. PLoS ONE. 7(11). e49829–e49829. 61 indexed citations
18.
Lanitis, Evripidis, Mathilde Poussin, Ian S. Hagemann, et al.. (2011). Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor. Molecular Therapy. 20(3). 633–643. 148 indexed citations
19.
Chiang, Cheryl Lai-Lai, Lana E. Kandalaft, Andrea Brennan, et al.. (2011). Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate. Journal of Translational Medicine. 9(1). 198–198. 24 indexed citations
20.
Galanis, Αlex, Aglaia Pappa, Antonis Giannakakis, et al.. (2008). Reactive oxygen species and HIF-1 signalling in cancer. Cancer Letters. 266(1). 12–20. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clare Y. Slaney Breakdown of academic impact, for papers by Elena Sotillo Breakdown of academic impact, for papers by Stefanie R. Bailey Breakdown of academic impact, for papers by Kheng Newick Breakdown of academic impact, for papers by Selene Nuñez-Cruz Breakdown of academic impact, for papers by Fabiana Perna Breakdown of academic impact, for papers by Liang‐Chuan S. Wang Breakdown of academic impact, for papers by Meera Murgai Breakdown of academic impact, for papers by Dhanalakshmi Chinnasamy Breakdown of academic impact, for papers by Olga Dakhova
Rankless by CCL
2026